BVCF Closes $188 Million China Private Equity Fund
April 09, 2014 at 06:01 AM EDT
BVCF, a China private equity growth investor specializing in healthcare and life sciences, has closed its third fund, BVCF III, L.P, with capital of $188 million (previously, BVCF was known as BioVeda). With the new fund, BVCF has over $360 million of assets under management. Headquartered in Shanghai, BVCF has been making private equity investments in China healthcare life science companies since its founding in 2005. More details.... Share this with colleagues: // //